公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation | SHIN-YI LIN ; Chang, Yu-Chen; FANG-JU LIN ; SUNG-CHUN TANG ; Dong Y.-H.; CHI-CHUAN WANG | Journal of the American Heart Association | 8 | 8 | |
2011 | Predicting healthcare utilization using a pharmacy-based metric with the WHO's anatomic therapeutic chemical algorithm | Kuo R.N.; Dong Y.-H.; Liu J.-P.; CHIA-HSUIN CHANG ; Shau W.-Y.; Lai M.-S. | Medical Care | 55 | 54 | |
2019 | Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study | Lin H.-M.D.; CHAO LUN LAI ; Dong Y.-H.; YU-KANG TU ; KIN-WEI CHAN ; Suissa S. | Drugs - Real World Outcomes | 10 | 8 | |
2014 | Statins and the risk of liver injury: A population-based case-control study | Chen G.-L.; FEI-YUAN HSIAO ; Dong Y.-H.; Shen L.-J.; Wu F.-L.L. | Pharmacoepidemiology and Drug Safety | 14 | 15 | |
2016 | Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study | Dong Y.-H.; CHIA-HSUIN CHANG ; Wu L.-C.; Lai M.-S. | European Journal of Clinical Pharmacology | 4 | 4 |